本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aldeyra Therapeutics Inc

1.77
-0.0700-3.80%
盤後1.770.0003+0.02%19:35 EDT
成交量:260.87萬
成交額:466.04萬
市值:1.06億
市盈率:-3.14
高:1.84
開:1.81
低:1.76
收:1.84
52周最高:6.73
52周最低:1.07
股本:6,016.28萬
流通股本:4,848.15萬
量比:0.40
換手率:5.38%
股息:- -
股息率:- -
每股收益(TTM):-0.5636
每股收益(LYR):-0.5636
淨資產收益率:-58.73%
總資產收益率:-24.95%
市淨率:2.41
市盈率(LYR):-3.14

資料載入中...

2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/22

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/19

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/04

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals